Physician profile
Roxene Riles
NPI 1518416510
$338.80
in general payments reported to CMS, 2019-2025
9 companies · $77.18 in 2025
The $77.18 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $27.15 · 2022: $33.25 · 2023: $15.74 · 2024: $185 · 2025: $77.18.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $278.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $278.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $85.92 | 2024-2025 | Airsupra |
| Pfizer INC. | $65.15 | 2024 | |
| Cranial Technologies, INC | $57.41 | 2021-2023 | Doc Band |
| Daiichi Sankyo INC. | $28.60 | 2024 | Injectafer |
| Abbvie INC. | $26.41 | 2025 | |
| Exact Sciences Corporation | $19.96 | 2024 | Cologuard Collection Kit |
| Glaxosmithkline, LLC. | $19.19 | 2025 | Trelegy Ellipta |
| Sanofi Pasteur INC. | $18.73 | 2022 | |
| Inari Medical, INC. | $17.43 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roxene Riles listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.